The American Journal of Managed Care5d
Prophylactic Cardiac Medication May Prolong Survival in DMD
Prophylactic cardiac treatment may prolong survival in Duchenne muscular dystrophy (DMD), but only one-quarter of individuals ...
Hosted on MSN14h
60 Degrees Pharmaceuticals obtains IRB approval for chronic babesiosis therapy trial
US-based pharmaceutical company 60 Degrees Pharmaceuticals has received approval from the investigational review board (IRB) ...
Medscape2d
Malaria Treatment and Prophylaxis in Endemic and Nonendemic Countries
The standard treatment for severe malaria has changed ... patients in endemic areas treated therapeutically and using prophylaxis (IPT) when indicated. The cost–effectiveness with respect ...
News Medical on MSN2d
Updated guidelines for preventing and managing hepatitis B virus reactivation
Researchers update clinical practice guidelines for how to prevent and monitor hepatitis B virus reactivation.
Medscape3d
Pediatric Urinary Tract Infections
Royal College of Physicians (1991) 1991–2000 Aggressive treatment, prophylaxis and investigation of all children aged <7 years [81] American Academy of Pediatrics Guideline (1999) Aggressive ...
60 Degrees Pharma Announces IRB Approval of Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis
Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with a ...
Daily14d
Extended treatment-dose antibiotic therapy bests low-dose prophylaxis for recurrent uncomplicated UTIs in postmenopausal women: Study
In a recent study, peri- and postmenopausal women with recurrent UTIs saw a 58% lower risk of recurrence with a 1-month ...
Business Wire13d
Shionogi Receives Award Through BARDA's Rapid Response Partnership Vehicle to Advance Long-Acting Formulation of S-892216, an Antiviral for COVID-19 Pre-Expo…
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) ...